Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Virology Journal

Fig. 3

From: Antiviral activity of Piscidin 1 against pseudorabies virus both in vitro and in vivo

Fig. 3

PRV inhibitory activity displayed by maculatin, piscidin and caerin (TCID50 assay). a PRV of Ea, HNXX strain and 152 isolate were treated with the peptides (50 μg/ml) for 1 h before they were added to the cell monolayers. The bars represent means ± standard errors of the means of three separate experiments (n = 3). *, Statistically significant difference by one-way ANOVA with Tukey post hoc test (P < 0.05), NS means not significant. b PRV Ea was treated with peptides (100 μg/ml) for 1 h before added to the cell monolayers. The effects of the peptides at 50 μg/ml and at 100 μg/ml against PRV Ea were compared

Back to article page